Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS

Journal of Mass Spectrometry

Volumn 48, Issue 2, 2013, Pages 243-249

  Meyer, Markus R ^a   Schmitt, Sara ^a   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

D2PM; designer drug; diphenylprolinol; GC MS; metabolism

Indexed keywords

D2PM; DESIGNER DRUGS; DETECTABILITY; DIPHENYLPROLINOL; DRUG OF ABUSE; FIVE PHASE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GC-MS; HUMAN URINE; ONLINE SHOPS; PYRROLIDINES; RAT URINE; TWO PHASE;

BODY FLUIDS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHYSIOLOGY; RATS;

METABOLISM;

DIPHENYL 2 PYRROLIDINEMETHANOL; PHENETHYLAMINE DERIVATIVE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; DRUG HYDROXYLATION; DRUG METABOLISM; HYDROGEN BOND; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; URINALYSIS;

ANIMALS; CHROMATOGRAPHY, LIQUID; DESIGNER DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; PYRROLIDINES; RATS; RATS, WISTAR; TANDEM MASS SPECTROMETRY;

EID: 84873340016     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.3142     Document Type: Article

References (20)

1. S. Gibbons,. 'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin. Toxicol. (Phila.) 2012, 50, 15.
2. S. D. Brandt,. Special issue on illicit drugs. Drug Test. Anal. 2011, 3, 525.
3. J. M. Corkery, S. Elliott, F. Schifano, O. Corazza, A. H. Ghodse,. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39, 253.
4. D. M. Wood, P. I. Dargan,. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin. Toxicol. (Phila.) 2012, 50, 727.
5. S. Lidder, P. Dargan, M. Sexton, J. Button, J. Ramsey, D. Holt, D. Wood,. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). J. Med. Toxicol. 2008, 4, 167.
6. D. M. Wood, M. Puchnarewicz, A. Johnston, P. I. Dargan,. A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur. J. Clin. Pharmacol. 2012, 68, 349.
7. P. G. De, S. D. Brandt, D. J. Pounder,. Analytical characterization and rapid determination of 2-(diphenylmethyl)pyrrolidine in blood and application to an internet product. J. Chromatogr. B 2011, 879, 3771.
8. D. B. Murray, S. Potts, C. Haxton, G. Jackson, E. A. Sandilands, J. Ramsey, M. Puchnarewicz, D. W. Holt, A. Johnston, B. D. Nicholas, J. W. Dear,. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clin. Toxicol. (Phila.) 2012, 50, 108.
9. H. H. Maurer, K. Pfleger, A. A. Weber,. Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Wiley-VCH: Weinheim, 2011.
10. H. H. Maurer, K. Pfleger, A. A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Wiley-VCH: Weinheim, 2011.
11. M. R. Meyer, C. Vollmar, A. E. Schwaninger, H. H. Maurer,. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J. Mass Spectrom. 2012, 47, 253.
12. D. K. Wissenbach, M. R. Meyer, D. Remane, A. A. Weber, H. H. Maurer,. Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants. Anal. Bioanal. Chem. 2011, 400, 79.
13. D. K. Wissenbach, M. R. Meyer, D. Remane, A. A. Philipp, A. A. Weber, H. H. Maurer,. Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal. Bioanal. Chem. 2011, 400, 3481.
14. A. H. Ewald, D. Ehlers, H. H. Maurer,. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2008, 390, 1837.
15. M. R. Meyer, F. T. Peters, H. H. Maurer,. Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin. Chem. 2010, 56, 575.
16. F. W. McLafferty, F. Turecek, Interpretation of Mass Spectra, University Science Books, Mill Valley, CA, 1993.
17. R. M. Smith, K. L. Busch, Understanding Mass Spectra-A Basic Approach, Wiley: New York (NY), 1999.
18. M. R. Meyer, P. Du, F. Schuster, H. H. Maurer,. Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS. J. Mass Spectrom. 2010, 45, 1426.
19. European Communities. European Union Decision 2002/657/EC 17.08.2002: commission decision laying down performance criteria for the analytical methods to be used for certain substances and residues thereof in live animals and animal products. Off. J. Eur. Commun. 2002, 221, 8.
20. D. Gerostamoulos,. MS identification guidelines in forensic toxicology-An Australian approach. TIAFT Bulletin 2012, 42, 52.